Agenus | 流动负债



金融业
股票价格
USD
资产
USD 233.89M
现金及等价物
USD 3.46M
销售成本
USD 137K
流动资产
USD 133.95M
流动负债
USD 287.13M
债务
USD 35.54M
股息收益率
0
EBIT
USD -13.31M
EBITDA
USD -10.11M
员工
389
EPS每股收益
USD -1.03
股本和储备
USD -274.14M
销售毛利
USD 23.93M
债务利息支出
USD 12.8M
贷款资金
USD 23.6M
市值
USD 1.28B
净收入
USD -25.27M
营业费用
USD -274.14M
营业利润
USD -13.31M
普通股股本
USD 266K
PE价格收益
17.82
税前利润
USD -274.14M
销售收入
USD 24.07M
销售和管理费用
USD 23.6M
贸易债权人
USD 85.29M
应收帐款人
USD 354K


流动负债 更改 日
AbbVie USD 39.39B 376M 2025-09
Agenus USD 287.13M 52.57M 2025-09
Amgen USD 25.49B 3.7B 2025-12
AstraZeneca USD 34.05B 518M 2025-09
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Celldex Therapeutics USD 46.46M 13.5M 2025-09
CSL USD 4.82B 1.26B 2025-06
Dynavax Technologies USD 106.84M 11.39M 2025-09
Eli Lilly USD 40.14B 1.12B 2025-09
Gilead Sciences USD 12.3B 1.11B 2025-09
GlaxoSmithKline GBP 21.39B 57M 2025-12
Glaxosmithkline GBP 28.68B 8.3B 2025-09
Incyte USD 1.52B 176.44M 2025-12
Intrexon USD 23.02M 38K 2024-06
J&J USD 50.87B 3.31B 2025-09
Jiangsu Hengrui CNY 7.85B 4.39B 2025-09
Karyopharm Therapeutics USD 87.16M 12.06M 2025-09
MacroGenics USD 44.47M 5.47M 2025-09
Merck EUR 8.64B 1.22B 2025-09
Merck USD 28.63B 2.59B 2025-09
Novartis USD 32B 286M 2025-09
Novavax USD 429.87M 40.73M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Veracyte USD 72.15M 4.28M 2025-09


Agenus 流动负债 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.